Search results for "Highlights"
Spotlight on efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
https://diabetes.acponline.org/archives/2022/05/13/5.htm
13 May 2022
No long-term disruption of glycemic control seen after COVID-19, study finds
The authors of a small Italian study of hospitalized COVID-19 patients speculated that reversible transient factors, such as inflammation-induced insulin resistance, may cause the hyperglycemia that occurs in some patients with and without diabetes during infection.
https://diabetes.acponline.org/archives/2021/11/12/2.htm
12 Nov 2021
Study finds long-term reductions in cardiovascular risk factors with SGLT-2 inhibitors
While the meta-analysis also found durable reductions in macrovascular complications and mortality with sodium-glucose cotransporter-2 (SGLT-2) inhibitors versus placebo, there were insufficient data comparing the drug class to other antihyperglycemic medications.
https://diabetes.acponline.org/archives/2021/12/10/2.htm
10 Dec 2021
Adults with diabetes more likely to report mental stress during the COVID-19 pandemic
An online survey of U.S. adults in mid-2020, most of whom were White women, found that those with diabetes were less likely to report resilience and more likely to experience depression than adults without diabetes.
https://diabetes.acponline.org/archives/2021/12/10/3.htm
10 Dec 2021
Newer oral diabetes meds could provide significant benefits in type 1 diabetes
A retrospective chart review found that glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors were associated with benefits including weight loss and reduced use of insulin in patients with type 1 diabetes.
https://diabetes.acponline.org/archives/2022/11/11/1.htm
11 Nov 2022
Recent KDIGO guideline focused on patients with diabetes and kidney disease
A new summary of the guideline from Kidney Disease: Improving Global Outcomes (KDIGO) highlights important points for clinicians, including recommendations about prescribing of diabetes medications.
https://diabetes.acponline.org/archives/2020/11/13/7.htm
13 Nov 2020
Depression associated with death in older patients with type 2 diabetes
A study that screened patients with type 2 diabetes in Spain for depression found that depression was associated with higher all-cause mortality in patients older than age 65 years, but not in younger patients.
https://diabetes.acponline.org/archives/2021/06/11/2.htm
11 Jun 2021
Diabetes incidence projected to increase among youth in U.S.
A modeling study using data from 2002-2017 found that incidence of type 1 and type 2 diabetes could increase in those under age 20 years by up to 65% and 673%, respectively, over the next three decades, although confidence intervals were wide.
https://diabetes.acponline.org/archives/2023/01/13/1.htm
13 Jan 2023
Self-monitoring of blood glucose reduced HbA1c in noninsulin-treated patients
Self-monitoring of blood glucose 8 to 11 times a week was more effective than doing so more or less frequently, according to a new meta-analysis.
https://diabetes.acponline.org/archives/2022/12/09/1.htm
9 Dec 2022
Type 1 and type 2 diabetes associated with increased risk of herpes zoster
Results of a systematic review and meta-analysis were consistent across age groups, diabetes types, and regions of the world. The study authors suggested that earlier vaccination against herpes zoster in all patients with diabetes, regardless of age, be considered.
https://diabetes.acponline.org/archives/2021/10/08/2.htm
8 Oct 2021